Mineralys Therapeutics股价上调2.5亿美元

• Mineralys Therapeutics (NASDAQ:MLYS) priced an upsized underwritten public offering of 9.8M shares at a public offering price of $25.50 per share.
• The aggregate gross proceeds to Mineralys from the offering are expected to be approximately $250.0 million.
• Underwriters have a 30-day option to purchase up to an additional ~1.47M shares of its common stock.
• The offering is expected to close on or about September 4, 2025.
• The stock price dropped ~3.5% on Tuesday during after market hours of trade.

More on Mineralys Therapeutics

• Mineralys Therapeutics, Inc. (MLYS) Q2 2025 Earnings Call Transcript
• Mineralys Therapeutics launches $175M public offering
• Mineralys surges after late-stage trial data AstraZeneca’s blood pressure drug
• Seeking Alpha’s Quant Rating on Mineralys Therapeutics
• Historical earnings data for Mineralys Therapeutics